About Jean Pierre Gagnon
Form D filings for Mid-Atlantic BioTherapeutics from 2018 to 2024 list Jean Pierre Gagnon as director.
Jean Pierre Gagnon first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Jean Pierre Gagnon in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jean Pierre Gagnon works with at each company, as listed on that company's latest Form D.
Mid-Atlantic BioTherapeutics, Inc. · Form D, Sep 30, 2024
JC
Julian Chick
Director
DH
David Horn
Chief Executive Officer and director
MG
Michael Goldblatt
Director
AK
Andrew Katz
Director
DJ
David Jobes
President and director